The Pathology of the Uremic Bone Lesion

  • Steven L. Teitelbaum


Renal osteodystrophy is a generic term that encompasses the array of biochemical and morphological derangements of bone that attend renal insufficiency. The insights gained into the genesis and, particularly, the natural history of this family of disorders are a reflection of the greater longevity of the uremic patient and, hence, the opportunity for skeletal dysfunctions to become clinically manifest.


Bone Biopsy Amorphous Calcium Phosphate Uremic Patient Renal Osteodystrophy Osteitis Fibrosa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Malluche HH, Ritz E, Lange HP, Kutschera J, Hodgson M, Seiffert, U, Schoeppe W: Bone histology in incipient and advanced renal failure. Kidney Int 9:355, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Cohen MEL, Cohen GF, Ahad V, Kaye M: Renal osteodystrophy in patients on chronic haemodialysis. A radiological study. Clin Radiol 21:124, 1970.PubMedCrossRefGoogle Scholar
  3. 3.
    Frost HM: Tetracycline-based histological analysis of bone remodeling. Cale Tiss Res 3:211, 1969.CrossRefGoogle Scholar
  4. 4.
    Milch RA, Rail DP, Tobie JE: Fluorescence of tetracycline antibiotics in bone. J Bone Joint Surg (AM) 40:897, 1958.Google Scholar
  5. 5.
    Urist MR, Ibsen KH: Chemical reactivity of mineralized tissue with Oxytetracycline. Arch Pathol 76:28, 1963.Google Scholar
  6. 6.
    Harris WH, Jackson RJ, Jowsey J: The in vivo distribution of tetracycline in canine bone. J Bone Joint Surg (AM) 44:1308, 1962.Google Scholar
  7. 7.
    Tam CS, Reed R, Cruickshand B: Bone growth kinetics: I. Modifications of the tetracycline labeling technique. J Pathol 113:27, 1973.CrossRefGoogle Scholar
  8. 8.
    Meunier P, Edouard C, Richard D, Laurent D: Histomorphometry of osteoid tissue. The hyperosteoidoses, in Meunier PJ (ed): Bone Histomorphometry. Toulouse, France, Sociétaé de la Nouvelle Imprimerie Fournié, 1977.Google Scholar
  9. 9.
    Termine JD: Mineral chemistry and skeletal biology. Clin Orthop 85:207, 1972.PubMedCrossRefGoogle Scholar
  10. 10.
    Burnell JM, Teubner E, Wergedal JE, Sherrard DJ: Bone crystal maturation in renal osteodystrophy in humans, J Clin Invest 53:52, 1974.PubMedCrossRefGoogle Scholar
  11. 11.
    Russell JE, Termine JD, Avioli LV: Abnormal bone mineral maturation in the chronic uremic state. J Clin Invest 52:2848, 1973.PubMedCrossRefGoogle Scholar
  12. 12.
    Teitelbaum SL, Hruska KA, Shieber W, Debnam JW, Nichols SH: Tetracycline fluorescence in uremic and primary hyperparathyroid bone. Kidney Int 12:366, 1977.PubMedCrossRefGoogle Scholar
  13. 13.
    Russell JE, Avioli LV, Mechanic G: The nature of the collagen cross-links in bone in the chronic uraemic state. Biochem J 145:119, 1975.PubMedGoogle Scholar
  14. 14.
    Teitelbaum SL, Bergfeld MA, Freitag J, Hruska KA: Accelerated bone formation in end stage renal disease, in Norman AW, Schaefer K, von Herrath D, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds): Vitamin D: Basic Research and Its Clinical Application. Berlin, Water de Gruyter, 1979, p. 373.Google Scholar
  15. 15.
    Canterbury JM, Reiss E: Multiple immunoreactive molecular forms of parathyroid hormone in human serum. Proc Soc Exp Biol Med 140:1393, 1972.PubMedGoogle Scholar
  16. 16.
    Canterbury JM, Levey GS, Reiss E: Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest 52:524, 1973.PubMedCrossRefGoogle Scholar
  17. 17.
    Eastwood JB, Stamp TCB, Harris E, De Wardener HE: Vitamin-D deficiency in the osteomalacia of chronic renal failure. Lancet 2:7997, 1976.Google Scholar
  18. 18.
    Goldstein DA, Oda Y, Kurokawa K, Massry SG: Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients. Ann Intern Med 87:664, 1977.PubMedGoogle Scholar
  19. 19.
    Shen F, Baylink DJ, Sherrard DJ, Shen L, Maloney NA, Wergedal JE: Serum immuno-reactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone disease. J Clin Endocrinol Metab 40:1009, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    Teitelbaum SL, Bone JM, Stein PM, Gilden JJ, Bates M, Boisseau VC, Avioli LV: Calcifediol in chronic renal insufficiency. Skeletal response. JAMA 235:164, 1976.PubMedCrossRefGoogle Scholar
  21. 21.
    Pierides AM, Skillen AW, Ellis HA: Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: A study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1αOHD3 and 1,25(OH)2D3. J Lab Clin Med 93:899, 1979.PubMedGoogle Scholar
  22. 22.
    Frost HM, Griffith DL, Jee WSS, Rimmel D, McCandlis RP Teitelbaum SL: Histomor-phometric changes in trabecular bone of renal failure patients treated with calcifediol. Metabol Bone Dis Rel Res 2:285, 1981.CrossRefGoogle Scholar
  23. 23.
    Russell JE, Roberts ML, Teitelbaum SL, Stein PM, Avioli LV: The therapeutic effects of 25-hydroxyvitamin D3 on renal osteodystrophy. Biochemical and morphometric analyses. Min Electrolyte Metab 1:129, 1978.Google Scholar
  24. 24.
    Eastwood JB, Bordier PJ, Clarkson EM, Tun Chot S, De Wardener HE: The contrasting effects on bone histology of vitamin D and of calcium carbonate in the osteomalacia of chronic renal failure. Clin Sci Mol Med 47:23, 1974.PubMedGoogle Scholar
  25. 25.
    Hruska KA, Teitelbaum SL, Kopelman R, Richardson CA, Miller P, Debnam J, Martin K, Slatopolsky E: The predictability of the histological features of uremic bone disease by non-invasive techniques. Metabol Bone Dis Rel Res 1:39, 1978.CrossRefGoogle Scholar
  26. 26.
    Mosekilde L, Meisen F: A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med Scand 204:97, 1978.PubMedCrossRefGoogle Scholar
  27. 27.
    Goldsmith RS: Discussion. Fed Proc 29:1198, 1970.PubMedGoogle Scholar
  28. 28.
    Goldsmith RS, Woodhouse CF, Ingbar SH, Segal D: Effect of phosphate supplements in patients with fractures. Lancet 1:7492, 1967.Google Scholar
  29. 29.
    Duursma SA, Visser WJ, Dorhout Mees EJ, Njio L: Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency. Calc Tiss Res 16:129, 1974.CrossRefGoogle Scholar
  30. 30.
    Sherrard DJ, Baylink DJ, Wergedal JE, Maloney NA: Quantitative histological studies on the pathogenesis of uremic bone disease. J Clin Endocrinol Metab 39:119, 1974.PubMedCrossRefGoogle Scholar
  31. 31.
    Debnam JW, Bates ML, Kopelman RC, Teitelbaum SL: Radiological/pathological correlations in uremic bone disease. Radiology 125:653, 1977.PubMedGoogle Scholar
  32. 32.
    Teitelbaum SL, Russell JE, Bone JM, Gilden JJ, Avioli LV: The relationship of biochemical and histometric determinants of uremic bone. Arch Pathol Lab Med 103:228, 1979.PubMedGoogle Scholar
  33. 33.
    Boskey AL, Posner AS: Magnesium stabilization of amorphous calcium phosphate: A kinetic study. Mat Res Bull 9:907, 1974.CrossRefGoogle Scholar
  34. 34.
    Ellis HA, McCarthy JH, Herrington J: Bone aluminum in haemodialyzed patients and in rats injected with aluminum chloride: Relationship to impaired bone mineralisation. J Clin Pathol 32:832, 1979.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Steven L. Teitelbaum
    • 1
  1. 1.Division of Bone and Mineral Metabolism, and Department of Pathology and Laboratory MedicineThe Jewish Hospital of St. Louis, Washington University School of MedicineSt. LouisUSA

Personalised recommendations